AMGN three-lens brief
Evidence-based stock research on AMGN. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Moved -2.25% yesterday. · Trading >3% below the 50-day MA — short-term weakness.
- Moved -2.25% yesterday.
- Trading >3% below the 50-day MA — short-term weakness.
- Debt-to-equity of 490% — balance-sheet-heavy.
AMGN closed at $382.47 (-2.25%) as of 2026-09-11. Market cap: $206.78B. P/E (trailing) 24.3. Price is below the 50-day MA and above the 200-day MA. Concerns: moved -2.25% yesterday.; trading >3% below the 50-day MA — short-term weakness.. Last quarter: Revenue $10.05B, net income $2.38B, free cash flow $8.65B.
Why three lenses on AMGN, not one.
A single reasoning model has blind spots it doesn’t know about. We examine AMGNacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/AMGN" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath AMGN brief"></iframe>